Augmentin 625mg TDS Dosing and Renal Adjustment
Augmentin 625mg three times daily (TDS) is an appropriate standard dose for adults with normal renal function, but requires dose reduction or interval extension when creatinine clearance falls below 30 mL/min to prevent drug accumulation and toxicity. 1
Standard Adult Dosing
- Standard dose: Augmentin 625mg (amoxicillin 500mg + clavulanic acid 125mg) administered three times daily is the established regimen for treating chronic rhinosinusitis and other moderate infections in adults with normal renal function 1
- Duration: Typical treatment courses range from 14-21 days depending on the infection type 1
- Administration: Can be taken with or without food, though taking with food may reduce gastrointestinal side effects 2
Renal Impairment Dosing Adjustments
Critical principle: Amoxicillin and clavulanic acid are both renally cleared, but amoxicillin accumulates more significantly than clavulanic acid in renal impairment, creating an increasing ratio of amoxicillin to clavulanic acid as kidney function declines 3
Specific Adjustments by Creatinine Clearance:
- CrCl 10-30 mL/min: Reduce frequency to 625mg twice daily (every 12 hours) 3
- CrCl <10 mL/min: Reduce to 625mg once daily (every 24 hours) 3
- Hemodialysis patients: Administer 625mg once daily, with an additional dose both during and at the end of dialysis, as both amoxicillin and clavulanic acid are significantly removed by hemodialysis (extraction ratios of 0.44 and 0.74 respectively) 4, 5
Pharmacokinetic Rationale:
The differential clearance between the two components creates a clinical challenge. In patients with GFR <10 mL/min, the amoxicillin-to-clavulanic acid AUC ratio increases to approximately 14.7:1 compared to 4.9:1 in normal renal function 3. This means:
- Amoxicillin accumulates more readily and requires dose reduction to prevent crystalluria and potential renal toxicity 2
- Clavulanic acid clears more efficiently even in renal impairment, maintaining adequate beta-lactamase inhibition 3
High-Flux Hemodialysis Considerations
Important caveat: High-flux hemodialysis removes both compounds more efficiently than conventional dialysis 6
- Twice-daily dosing (625mg every 12 hours) maintains adequate probability of target attainment (PTA ≥90%) for both compounds 6
- Once-daily dosing results in insufficient clavulanic acid concentrations (PTA 20-30%) and should be avoided 6
- Timing: Administer dose after dialysis to prevent premature drug removal 5
Monitoring and Safety
Key Monitoring Parameters:
- Renal function: Assess creatinine clearance before initiating therapy and monitor in patients with any degree of renal insufficiency 2
- Fluid status: Maintain adequate hydration to reduce risk of amoxicillin crystalluria, particularly in overdose or renal impairment 2
- Clinical response: Gastrointestinal symptoms (diarrhea, vomiting, abdominal pain) are the most common adverse effects 2
Common Pitfalls to Avoid:
- Do not use standard dosing in CrCl <30 mL/min: This leads to excessive amoxicillin accumulation and increased toxicity risk 3
- Do not assume serum creatinine reflects true renal function: Elderly patients and those with reduced muscle mass may have normal serum creatinine despite significant renal impairment 7
- Do not use once-daily dosing in dialysis patients on high-flux membranes: This results in subtherapeutic clavulanic acid levels 6
Special Populations
Critically Ill Patients with Augmented Renal Clearance (ARC):
- Paradoxically, 30-65% of critically ill patients have enhanced renal clearance (CrCl >130 mL/min) despite normal serum creatinine 8
- Standard dosing may result in subtherapeutic concentrations in ARC patients 8
- Consider increased dosing frequency or higher doses (e.g., 1000mg/125mg TDS) with therapeutic drug monitoring when available 8